Combined use of a trka inhibitor and an epha2 inhibitor for using in the treatment of solid cancers, and method for the prognosis of survival of a patient who has a solid cancer
US-2017258871-A1 · Sep 14, 2017 · US
Guilbert Matthieu is listed as an inventor on 1 patent in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Guilbert Matthieu |
| Total patents | 1 |
| First publication | Sep 14, 2017 |
| Latest publication | Sep 14, 2017 |
Publications ranked by popularity score, then publication date.
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Des Sciences Et Tech De Lille | 1 |
| Inserm (Institut Nat De La Sante Et Res Medecale) | 1 |
| Inserm (Institut Nat De La Sante Et De La Rech Medicale) | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K38/177 | 1 |
| G01N2333/705 | 1 |
| A61K31/553 | 1 |
| A61K45/06 | 1 |
| A61P35/00 | 1 |